Summary & Overview
CPT 90732: Pneumococcal Polysaccharide Vaccine Administration, Age 2+
CPT code 90732 denotes administration of the pneumococcal polysaccharide vaccine (PPSV) by intramuscular or subcutaneous injection for individuals aged two years and older. This preventive immunization reduces risk of invasive pneumococcal disease, including meningitis and pneumonia, and is a routine element of adult and certain pediatric vaccination programs. Nationally, pneumococcal vaccination is a key public health measure that influences outpatient immunization workflows, supply management, and preventive care quality metrics.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of coverage considerations, typical sites of service (ambulatory and outpatient settings), and the clinical context surrounding use of the vaccine for eligible patients. The publication summarizes common billing modifiers and service-line implications, and highlights benchmarks and policy updates relevant to immunization billing practice. It also outlines typical documentation elements and places the code within broader preventive care and population health efforts. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 90732 describes administration of the pneumococcal polysaccharide vaccine by intramuscular or subcutaneous injection in an individual aged two years or older. The service provides immunization against Streptococcus pneumoniae strains that can cause meningitis and pneumonia.
-
Service type: Vaccine administration
-
Typical site of service: Outpatient clinics, physician offices, community health centers, and other ambulatory care settings
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult aged two years or older presenting to a primary care clinic, occupational health clinic, pharmacy clinic, or public health department visit for routine immunization or for catch-up pneumococcal protection. The patient may have routine preventive care scheduled, a chronic medical condition (for example, chronic obstructive pulmonary disease, diabetes mellitus, or asplenia) that increases risk for invasive pneumococcal disease, or be due for pneumococcal polysaccharide vaccine after prior conjugate vaccine per immunization schedule. The clinical workflow includes verification of vaccination history and contraindications, obtaining informed consent, administration of 90732 intramuscularly or subcutaneously (typically into the deltoid for adults), documentation of vaccine manufacturer, lot number, expiration date, site and route of administration, and counseling on expected local/systemic reactions. Billing is submitted by the administering provider or facility with appropriate modifier(s) as indicated by the encounter and payer requirements. Typical sites of service are outpatient physician offices, community clinics, retail pharmacies (where authorized by state law), and public health clinics.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Modifier not typically used; placeholder for payor-defined use | Use only if a specific payor requires this internal modifier (rare) |